Correlation Between CannaPharmaRx and Patient Access

Can any of the company-specific risk be diversified away by investing in both CannaPharmaRx and Patient Access at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CannaPharmaRx and Patient Access into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CannaPharmaRx and Patient Access Solutions, you can compare the effects of market volatilities on CannaPharmaRx and Patient Access and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CannaPharmaRx with a short position of Patient Access. Check out your portfolio center. Please also check ongoing floating volatility patterns of CannaPharmaRx and Patient Access.

Diversification Opportunities for CannaPharmaRx and Patient Access

-0.08

Correlation Coefficient

CannaPharmaRx  Patient Access

Good diversification

The 3 months correlation between CannaPharmaRx and Patient is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding CannaPharmaRx and Patient Access Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Patient Access Solutions and CannaPharmaRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CannaPharmaRx are associated (or correlated) with Patient Access. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Patient Access Solutions has no effect on the direction of CannaPharmaRx i.e., CannaPharmaRx and Patient Access go up and down completely randomly.

Pair Corralation between CannaPharmaRx and Patient Access

Given the investment horizon of 90 days CannaPharmaRx is expected to under-perform the Patient Access. But the pink sheet apears to be less risky and, when comparing its historical volatility, CannaPharmaRx is 12.68 times less risky than Patient Access. The pink sheet trades about 0.0 of its potential returns per unit of risk. The Patient Access Solutions is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Patient Access Solutions on May 18, 2025 and sell it today you would earn a total of  0.00  from holding Patient Access Solutions or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CannaPharmaRx  vs.  Patient Access Solutions

CannaPharmaRx

Risk-Adjusted Performance

Weakest

Over the last 90 days CannaPharmaRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, CannaPharmaRx is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Patient Access Solutions

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Patient Access Solutions are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Patient Access displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CannaPharmaRx and Patient Access

The main advantage of trading using opposite CannaPharmaRx and Patient Access positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CannaPharmaRx position performs unexpectedly, Patient Access can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Patient Access will offset losses from the drop in Patient Access' long position.

The idea behind CannaPharmaRx and Patient Access Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.